Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes.

Autogenous cancellous bone graft is used to heal critical-size segmental long bone defects and defects in the maxillofacial skeleton. Harvesting of bone graft is traumatic, causes morbidity of the donor site, and often results in complications. Thus, there is a need for new biologically functional bone graft substitutes that, instead of autogenous bone graft, could be used to facilitate bone regeneration in critical-size defects. Porous biodegradable elastomeric polyurethane scaffolds combined with the patient's own bone marrow could potentially be such bone substitutes. The elastomeric bone substitute prevents shear forces at the interface between bone and rigid, e.g., ceramic bone substitutes and establishes an intimate contact with the native bone ends, thus facilitating the proliferation of osteogenic cells and bone regeneration. Crosslinked 3D biodegradable polyurethane scaffolds (foams) with controlled hydrophilicity for bone graft substitutes were synthesized from biocompatible reactants. The scaffolds had hydrophilic-to-hydrophobic content ratios of 70:30, 50:50, and 30:70. The reactants used were hexamethylene diisocyanate, poly(ethylene oxide) diol (MW = 600) (hydrophilic component), and poly(epsilon-caprolactone) diol (M(w) = 2000), amine-based polyol (M(w) = 515) or sucrose-based polyol (M(w) = 445) (hydrophobic component), water as the chain extender and foaming agent, and stannous octoate, dibutyltin dilaurate, ferric acetylacetonate, and zinc octoate as catalysts. Citric acid was used as a calcium complexing agent, calcium carbonate, glycerol phosphate calcium salt, and hydroxyapatite were used as inorganic fillers, and lecithin or solutions of vitamin D(3) were used as surfactants. The scaffolds had an open-pore structure with pores whose size and geometry depended on the material's chemical composition. The compressive strengths of the scaffolds were in the range of 4-340 kPa and the compressive moduli in the range of 9-1960 kPa, the values of which increased with increasing content of polycaprolactone. Of the two materials with the same amount of polycaprolactone the compressive strengths and moduli were higher for the one containing inorganic fillers. The scaffolds absorbed water and underwent controlled degradation in vitro. The amount of absorbed water and susceptibility to degradation increased with the increasing content of the polyethylene oxide segment in the polymer chain and the presence in the material of calcium complexing moiety. All polyurethane scaffolds induced the deposition of calcium phosphate crystals, the structure and calcium:phosphorus atomic ratio of which depended on the chemical composition of the polyurethane and varied from 1.52-2.0.

[1]  S. Gogolewski,et al.  BIODEGRADABLE MATERIALS OF POLYLACTIDES, .4. POROUS BIOMEDICAL MATERIALS BASED ON MIXTURES OF POLYLACTIDES AND POLYURETHANES , 1982 .

[2]  A. Takahara,et al.  Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipid sorption. , 1992, Journal of biomedical materials research.

[3]  C. G. Pitt,et al.  Modification of the rates of chain cleavage of poly(ϵ-caprolactone) and related polyesters in the solid state , 1987 .

[4]  F. Tan,et al.  Ionic Interactions of Polyurethanes , 1988, Journal of biomaterials applications.

[5]  Sylwester Gogolewski,et al.  Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(epsilon-caprolactone)-poly(ethylene oxide) diols and various chain extenders. , 2002, Journal of biomedical materials research.

[6]  D J Wheatley,et al.  Polyurethane heart valves: fatigue failure, calcification, and polyurethane structure. , 1997, Journal of biomedical materials research.

[7]  James P. Braselton,et al.  Technology and Applications , 1997 .

[8]  J. A. Hubbell,et al.  Rapidly degraded terpolymers of dl-lactide, glycolide, and epsilon-caprolactone with increased hydrophilicity by copolymerization with polyethers. , 1990, Journal of biomedical materials research.

[9]  S. Gogolewski,et al.  Polyurethane vascular prostheses in pigs , 1987 .

[10]  D. Han,et al.  In vivo biostability and calcification-resistance of surface-modified PU-PEO-SO3. , 1993, Journal of biomedical materials research.

[11]  S. Gogolewski,et al.  Novel Biodegradable Polyurethanes for Medical Applications , 2000 .

[12]  J. Andrade,et al.  Calcification of nontextured implantable blood pumps. , 1981, Transactions - American Society for Artificial Internal Organs.

[13]  R. J. Thoma Poly(ether) Urethane Reactivity with Metal-Ion in Calcification and Environmental Stress Cracking , 1986, Journal of biomaterials applications.

[14]  G. Golomb Calcification of polyurethane-based biomaterials implanted subcutaneously in rats: role of porosity and fluid absorption in the mechanism of mineralization , 1992 .

[15]  S. Gogolewski Liquid-induced crystallization and annealing of polyester-urethane elastomers , 1978 .

[16]  C. S. Schollenberger,et al.  Thermoplastic Polyurethane Hydrolysis Stability , 1971 .

[17]  T. Yamamuro,et al.  Apatite coated on organic polymers by biomimetic process: improvement in adhesion to substrate by HCl treatment , 1995 .

[18]  S. Gogolewski,et al.  In vitro degradation of novel medical biodegradable aliphatic polyurethanes based on ϵ-caprolactone and Pluronics® with various hydrophilicities , 2002 .

[19]  S. Gogolewski,et al.  Molecular stability, mechanical properties, surface characteristics and sterility of biodegradable polyurethanes treated with low-temperature plasma☆ , 2003 .

[20]  Anne Hiltner,et al.  Recent advances in biomedical polyurethane biostability and biodegradation , 1998 .

[21]  S. Gogolewski,et al.  The effect of gamma radiation on molecular stability and mechanical properties of biodegradable polyurethanes for medical applications , 2003 .

[22]  J. Szivek,et al.  Characterization of three formulations of a synthetic foam as models for a range of human cancellous bone types. , 1995, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[23]  F. Benoit Degradation of polyurethane foams used in the Même breast implant. , 1993, Journal of biomedical materials research.

[24]  S. Gogolewski,et al.  An artificial skin based on biodegradable mixtures of polylactides and polyurethanes for full-thickness skin wound covering , 1983 .

[25]  R Guidoin,et al.  Assessing the resistance to calcification of polyurethane membranes used in the manufacture of ventricles for a totally implantable artificial heart. , 1999, Journal of biomedical materials research.

[26]  M. Okada,et al.  Swelling behavior and controlled release of new hydrolyzable poly(ether urethane) gels derived from saccharide and L‐lysine derivatives and poly(ethylene glycol) , 1996 .

[27]  C. Batich,et al.  Toxic hydrolysis product from a biodegradable foam implant. , 1989, Journal of biomedical materials research.

[28]  S. Gogolewski,et al.  Polyurethane microporous membranes as pericardial substitutes , 1987 .